{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:03:48Z","timestamp":1777356228032,"version":"3.51.4"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1097\/mop.0b013e32833b6ac3","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T08:20:58Z","timestamp":1278577258000},"page":"445-452","source":"Crossref","is-referenced-by-count":32,"title":["Update on childhood vitiligo"],"prefix":"10.1097","volume":"22","author":[{"given":"Nanette B","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210206","first-page":"370","article-title":"Childhood vitiligo","volume":"77","author":"Silverberg","year":"2006","journal-title":"Cutis"},{"key":"R2-11-20210206","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0190-9622(87)70119-4","article-title":"Childhood vitiligo","volume":"16","author":"Halder","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R3-11-20210206","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2006.09.010","article-title":"Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo","volume":"6","author":"Kemp","year":"2007","journal-title":"Autoimmun Rev"},{"key":"R4-11-20210206","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1440-0960.2005.00167.x","article-title":"Childhood vitiligo: a prospective hospital-based study","volume":"46","author":"Al-Mutairi","year":"2005","journal-title":"Australas J Dermatol"},{"key":"R5-11-20210206","first-page":"300","article-title":"Autoantibodies and their clinical significance in a black vitiligo population","volume":"119","author":"Grimes","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"R6-11-20210206","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific cytotoxic T lymphocyte responses against Melan-A\/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex\/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"R8-11-20210206","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2249.1998.00746.x","article-title":"Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)","volume":"114","author":"Kemp","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"R9-11-20210206","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/labinvest.3700438","article-title":"Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patients","volume":"86","author":"Gottumukkala","year":"2006","journal-title":"Lab Invest"},{"key":"R11-11-20210206","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J Invest Dermatol"},{"key":"R12-11-20210206","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0749.2004.00130.x","article-title":"On the etiology of contact\/occupational vitiligo","volume":"17","author":"Boissy","year":"2004","journal-title":"Pigment Cell Res"},{"key":"R13-11-20210206","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2007.07.012","article-title":"Apoptosis of melanocytes in vitiligo results from antibody penetration","volume":"29","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"J Autoimmun"},{"key":"R14-11-20210206","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/1523-1747.ep12476645","article-title":"Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation","volume":"100","author":"Le Poole","year":"1993","journal-title":"J Invest Dermatol"},{"key":"R15-11-20210206","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0019-5154.57604","article-title":"Vitiligo and the melanocyte reservoir","volume":"54","author":"Falabella","year":"2009","journal-title":"Indian J Dermatol"},{"key":"R16-11-20210206","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N Engl J Med"},{"key":"R17-11-20210206","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0749.2007.00393.x","article-title":"NALP1 and the inflammasomes: challenging our perception of vitiligo and vitiligo-related autoimmune disorders","volume":"20","author":"Ta\u00efeb","year":"2007","journal-title":"Pigment Cell Res"},{"key":"R18-11-20210206","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMoa0908547","article-title":"Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo","volume":"362","author":"Jin","year":"2010","journal-title":"N Engl J Med"},{"key":"R19-11-20210206","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.4049\/jimmunol.0713370","article-title":"Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling","volume":"182","author":"Arechiga","year":"2009","journal-title":"J Immunol"},{"key":"R20-11-20210206","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1755-148X.2008.00443.x","article-title":"The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population","volume":"21","author":"Laberge","year":"2008","journal-title":"Pigment Cell Melanoma Res"},{"key":"R21-11-20210206","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/jid.2009.273","article-title":"Fine-mapping of vitiligo susceptibility loci on chromosomes 7 and 9 and interactions with NLRP1 (NALP1)","volume":"130","author":"Jin","year":"2010","journal-title":"J Invest Dermatol"},{"key":"R22-11-20210206","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1468-3083.2006.01686.x","article-title":"MHC haplotypic association in Chinese Han patients with vitiligo","volume":"20","author":"Xia","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R23-11-20210206","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0019-5154.55628","article-title":"Oxidative stress in experimental vitiligo C57BL\/6 mice","volume":"54","author":"Jalel","year":"2009","journal-title":"Indian J Dermatol"},{"key":"R24-11-20210206","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0019-5154.48978","article-title":"Study of total antioxidant status and glutathione peroxidase activity in tunisian vitiligo patients","volume":"54","author":"Jalel","year":"2009","journal-title":"Indian J Dermatol"},{"key":"R25-11-20210206","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF03260057","article-title":"Catalase enzyme mutations and their association with diseases","volume":"8","author":"G\u00f3th","year":"2004","journal-title":"Mol Diagn"},{"key":"R26-11-20210206","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcp.22027","article-title":"Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients","volume":"223","author":"Dell'Anna","year":"2010","journal-title":"J Cell Physiol"},{"key":"R27-11-20210206","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2133.2009.09288.x","article-title":"Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo","volume":"161","author":"Zhou","year":"2009","journal-title":"Br J Dermatol"},{"key":"R28-11-20210206","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1525-1470.2006.00208.x","article-title":"Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a noninvasive colorimetric assessment","volume":"23","author":"Brazzelli","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"R29-11-20210206","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1600-0560.2008.01134.x","article-title":"Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma","volume":"36","author":"Gowda","year":"2009","journal-title":"J Cutan Pathol"},{"key":"R30-11-20210206","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-4632.2006.02907.x","article-title":"Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China","volume":"45","author":"Sun","year":"2006","journal-title":"Int J Dermatol"},{"key":"R31-11-20210206","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"R32-11-20210206","first-page":"463","article-title":"Thyroid abnormalities in pediatric patients with vitiligo in New York City","volume":"81","author":"Pagovich","year":"2008","journal-title":"Cutis"},{"key":"R33-11-20210206","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jaad.2006.02.027","article-title":"The relationship between family medical history and childhood vitiligo","volume":"55","author":"Pajvani","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R34-11-20210206","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jaad.2005.03.032","article-title":"Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo","volume":"53","author":"Kakourou","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R35-11-20210206","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0749.2005.00242.x","article-title":"Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo","volume":"18","author":"Laberge","year":"2005","journal-title":"Pigment Cell Res"},{"key":"R36-11-20210206","first-page":"323","article-title":"Clinical predictors of outcome in vitiligo","volume":"68","author":"Dave","year":"2002","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R37-11-20210206","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","article-title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","volume":"159","author":"Sampogna","year":"2008","journal-title":"Br J Dermatol"},{"key":"R39-11-20210206","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaad.2008.06.023","article-title":"Therapeutic interventions for vitiligo","volume":"59","author":"Whitton","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R40-11-20210206","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"R41-11-20210206","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0019-5154.57613","article-title":"Vitiligo treatment with vitamins, minerals and polyphenol supplementation","volume":"54","author":"Jalel","year":"2009","journal-title":"Indian J Dermatol"},{"key":"R43-11-20210206","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0091270009335769","article-title":"Response of vitiligo to narrowband ultraviolet B and oral antioxidants","volume":"49","author":"Elgoweini","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"R44-11-20210206","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-5945-8-2","article-title":"A systematic review of natural health product treatment for vitiligo","volume":"8","author":"Szczurko","year":"2008","journal-title":"BMC Dermatol"},{"key":"R45-11-20210206","first-page":"720","article-title":"Is there a relationship between homocysteine and vitiligo? A pilot study","volume":"159","author":"Shaker","year":"2008","journal-title":"Br J Dermatol"},{"key":"R46-11-20210206","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1684\/ejd.2009.0671","article-title":"Serum homocysteine, folic acid and vitamin B12 levels in vitiligo","volume":"19","author":"Balci","year":"2009","journal-title":"Eur J Dermatol"},{"key":"R47-11-20210206","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/0378-6323.48427","article-title":"Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and nonvitiliginous skin","volume":"75","author":"Sravani","year":"2009","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R48-11-20210206","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-4362.2002.01463.x","article-title":"Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS)","volume":"41","author":"Schallreuter","year":"2002","journal-title":"Int J Dermatol"},{"key":"R49-11-20210206","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2133.2009.09252.x","article-title":"A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo","volume":"161","author":"Bakis-Petsoglou","year":"2009","journal-title":"Br J Dermatol"},{"key":"R50-11-20210206","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1525-1470.2000.01749.x","article-title":"Characteristics of vitiligo in Korean children","volume":"17","author":"Cho","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"R51-11-20210206","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3928\/00904481-20090522-01","article-title":"Vitiligo: treatment approach in children","volume":"38","author":"Isenstein","year":"2009","journal-title":"Pediatr Ann"},{"key":"R52-11-20210206","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2008.08881.x","article-title":"Guideline for the diagnosis and management of vitiligo","volume":"159","author":"Gawkrodger","year":"2008","journal-title":"Br J Dermatol"},{"key":"R53-11-20210206","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.0736-8046.2004.21418.x","article-title":"Calcipotriene and corticosteroid combination therapy for vitiligo","volume":"21","author":"Travis","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"R54-11-20210206","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.139.5.571","article-title":"Successful treatment of vitiligo with 0.1% tacrolimus ointment","volume":"139","author":"Travis","year":"2003","journal-title":"Arch Dermatol"},{"key":"R55-11-20210206","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","article-title":"Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases","volume":"51","author":"Silverberg","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R56-11-20210206","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2230.2004.01632.x","article-title":"Topical tacrolimus for treatment of childhood vitiligo in Asians","volume":"29","author":"Kanwar","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"R57-11-20210206","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1468-3083.2009.03138.x","article-title":"Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial","volume":"23","author":"Radakovic","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R58-11-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00403-009-0973-3","article-title":"Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus","volume":"302","author":"Lubaki","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"R59-11-20210206","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/archderm.144.4.560","article-title":"Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus","volume":"144","author":"Mikhail","year":"2008","journal-title":"Arch Dermatol"},{"key":"R60-11-20210206","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/09546630601028711","article-title":"Topical pimecrolimus: a new horizon for vitiligo treatment?","volume":"17","author":"Sendur","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"R61-11-20210206","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-4632.2007.03282.x","article-title":"Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream","volume":"46","author":"Souza Leite","year":"2007","journal-title":"Int J Dermatol"},{"key":"R62-11-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"R63-11-20210206","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1468-3083.2006.02101.x","article-title":"Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients","volume":"21","author":"Fai","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R64-11-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1525-1470.2009.00914.x","article-title":"Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo","volume":"26","author":"Hui-Lan","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"R65-11-20210206","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1525-1470.2009.00926.x","article-title":"The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study","volume":"26","author":"Farajzadeh","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"R66-11-20210206","first-page":"13","article-title":"Using a 308-nm excimer laser to treat vitiligo in Asians","volume":"18","author":"Al-Otaibi","year":"2009","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"R67-11-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/pho.2006.24.354","article-title":"Treatment of vitiligo using the 308-nm excimer laser","volume":"24","author":"Hadi","year":"2006","journal-title":"Photomed Laser Surg"},{"key":"R68-11-20210206","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","article-title":"Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo\u2013a multicentre controlled study","volume":"21","author":"Casacci","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R69-11-20210206","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/pho.2007.2086","article-title":"Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck","volume":"25","author":"Shen","year":"2007","journal-title":"Photomed Laser Surg"},{"key":"R70-11-20210206","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi","year":"2008","journal-title":"Br J Dermatol"},{"key":"R71-11-20210206","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0781.2006.00250.x","article-title":"Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo","volume":"22","author":"Lu-yan","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R72-11-20210206","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.42905","article-title":"An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad\/narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R73-11-20210206","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R74-11-20210206","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-4632.2008.03356.x","article-title":"Dihydroxyacetone: a safe camouflaging option in vitiligo","volume":"47","author":"Rajatanavin","year":"2008","journal-title":"Int J Dermatol"},{"key":"R75-11-20210206","first-page":"110","article-title":"Corrective camouflage in pediatric dermatology","volume":"79","author":"Tedeschi","year":"2007","journal-title":"Cutis"},{"key":"R76-11-20210206","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.1977.tb14275.x","article-title":"Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature","volume":"97","author":"Mosher","year":"1977","journal-title":"Br J Dermatol"},{"key":"R77-11-20210206","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-4632.2005.02697.x","article-title":"Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)\u2013a prospective study","volume":"45","author":"Lahiri","year":"2006","journal-title":"Int J Dermatol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e32833b6ac3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T19:24:16Z","timestamp":1740252256000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201008000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32833b6ac3","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}